Prestige Consumer Posts $1.13 Adjusted EPS for Fiscal Q2
PBH sits 18% above its 52-week low of $42.62.
Summary
Prestige Consumer Healthcare reported fiscal second-quarter adjusted EPS of $1.13, alongside net income of $25.3M and revenue of $336.3M. The print lands against a soft baseline: last quarter revenue rose 6.5% on the $1.045B Breathe Right acquisition while net income fell 38.5% on acquisition costs, so the adjusted figure is the number that strips out those deal charges. The company has been leaning on buybacks and acquisitions to offset a declining core, and this quarter's adjusted number is the first clean read on whether that strategy is holding.
At the time of this announcement, PBH was trading at $50.50 on NYSE in the Trade & Services sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $42.62 to $71.07. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.